Company / Return on Equity (ROE)
Insulet Corporation Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
16.3%
FY2025
5-year range
1.0% / 34.5%
FY2021-FY2025
Trend
-52.8%
vs FY2024
Sector context
#25 of 147
Health Care
What the data says
Insulet Corporation's return on equity (roe) of 16.3% is higher than 83% of companies in the Health Care sector (FY2025). Return on Equity (ROE) has fluctuated over the past 10 years, ranging from -45.8% in FY2016 to 34.5% in FY2024.
Based on SEC 10-K filings.
16.3% in FY2025 with a 5-year CAGR of +15.2%. Top quartile in the Health Care sector.
Declined from 28.2% to 16.3% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +15.3pp
- 5-Year Change
- +15.2pp
- 10-Year Change
- -
Sector benchmark
+622.6% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 52.8% year-over-year.
- Currently 19.4pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2024.
- Lowest return on equity (roe) in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 16.3% | -52.8% |
| FY2024 | 34.5% | +22.6% |
| FY2023 | 28.2% | +2803.1% |
| FY2022 | 1.0% | -67.9% |
| FY2021 | 3.0% | +167.3% |
| FY2020 | 1.1% | -92.6% |
| FY2019 | 15.3% | +879.5% |
| FY2018 | 1.6% | +109.2% |
| FY2017 | -16.9% | +63.1% |
| FY2016 | -45.8% | +78.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026